Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Teamgene Technology Co's earnings before interest and taxes (EBIT) for the
three
months ended in Mar. 2026 was ¥9 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥126 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Shandong Teamgene Technology Co's annualizedROC % for the quarter that ended in Mar. 2026 was 6.48%.
Shandong Teamgene Technology Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.62%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Shandong Teamgene Technology Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.29%.
Shandong Teamgene Technology Co (SHSE:603151) EBIT Explanation
1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Shandong Teamgene Technology Co's annualizedROC % for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Teamgene Technology Co EBIT Related Terms
Shandong Teamgene Technology Co EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Farm Products subindustry, Shandong Teamgene Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Teamgene Technology Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Shandong Teamgene Technology Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Shandong Teamgene Technology Co's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥126 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Teamgene Technology Co (SHSE:603151) has a EBIT of ¥126 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shandong Teamgene Technology Co.
Is Shandong Teamgene Technology Co's EBIT too high?
Shandong Teamgene Technology Co's current EBIT is ¥126 Mil. Overall, Shandong Teamgene Technology Co has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shandong Teamgene Technology Co's EBIT compare to ADM and BG?
Shandong Teamgene Technology Co's EBIT of ¥126 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shandong Teamgene Technology Co. Shandong Teamgene Technology Co's current EBIT is ¥126 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Teamgene Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Teamgene Technology Co (SHSE:603151) is currently considered Possible Value Trap. The stock's GF Value™ is ¥33.54, compared to a current price of ¥12.24 — trading 63.5% below its estimated fair value. The current EBIT is ¥126 Mil. Shandong Teamgene Technology Co's overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Shandong Teamgene Technology Co (SHSE:603151), the current EBIT is ¥126 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Teamgene Technology Co (SHSE:603151) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Teamgene Technology Co stock appears to be undervalued.
The current stock price of ¥12.24 is trading 63.5% below its estimated GF Value™ of ¥33.54.
GuruFocus considers Shandong Teamgene Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:603151:
EBIT: ¥126 Mil
GF Value™: ¥33.54 vs. price of ¥12.24 (63.5% below fair value)
No single metric tells the full story. See the SHSE:603151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Teamgene Technology Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603151 has been successfully added to your 
